Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case–control and 25 cohort studies
Fan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Han Lei(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jingfu Qiu(Chongqing Public Health Medical Center), Dayi Hu(Beihang University), Chunguang Wong(Chongqing Medical University), Yang Wang(Chongqing Public Health Medical Center), Yuan Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Laura Skrip(London School of Hygiene & Tropical Medicine)
Cited by 51
Related Papers
A pan-cancer proteomic perspective on The Cancer Genome Atlas
|Nature Communications|2014|641
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|New England Journal of Medicine|2013|603
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
|The Lancet Diabetes & Endocrinology|2017|325
A review and agenda for integrated disease models including social and behavioural factors
|Nature Human Behaviour|2021|227